Singapore markets closed
Straits Times Index
3,230.55 +21.37 (+0.67%) Nikkei
26,781.68 +176.84 (+0.66%) Hang Seng
20,697.36 +581.16 (+2.89%) FTSE 100
7,585.46 +20.54 (+0.27%) BTC-USD
28,803.33 -798.70 (-2.70%) CMC Crypto 200
625.79 -3.71 (-0.59%)
Organon & Co. (OGN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
At close: 04:04PM EDT
After hours:
| Previous close | 38.56 |
| Open | 38.50 |
| Bid | 37.29 x 900 |
| Ask | 39.00 x 800 |
| Day's range | 38.28 - 38.95 |
| 52-week range | 27.25 - 39.47 |
| Volume | |
| Avg. volume | 2,021,088 |
| Market cap | 9.866B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 7.63 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.12 (2.99%) |
| Ex-dividend date | 13 May 2022 |
| 1y target est | N/A |
- Business Wire
Organon Reports Results for the First Quarter Ended March 31, 2022
JERSEY CITY, N.J., May 05, 2022--Organon (NYSE: OGN) (the "company"), today announced its results for the first quarter ended March 31, 2022.
- Business Wire
Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
JERSEY CITY, N.J., April 21, 2022--Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
- Business Wire
Organon Enters into Global License Agreement to Commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%), FDA-Approved Treatment for Females 12 and Older with Bacterial Vaginosis (BV)
JERSEY CITY, N.J. & SAN DIEGO, March 31, 2022--Organon Enters into Global License Agreement to commercialize Daré Bioscience’s XACIATO™ (clindamycin phosphate vaginal gel, 2%)
© 2022 Yahoo. All rights reserved.
